logo
Indian-Origin Engineer Anantha Chandrakasan Named MIT Provost

Indian-Origin Engineer Anantha Chandrakasan Named MIT Provost

NDTV18-06-2025
New York:
Prof Anantha Chandrakasan has been named Massachusetts Institute of Technology's new provost, the first Indian-American to serve in this leadership role.
Chennai-born Mr Chandrakasan, who is MIT's chief innovation and strategy officer and Dean of Engineering, will begin his new role on July 1.
MIT President Sally Kornbluth, in making the announcement, said that Mr Chandrakasan was chosen from a group of outstanding internal candidates and brings to this post an exceptional record of shaping and leading important innovations for the Institute.
The MIT provost is the institute's chief academic and budget officer, with a wide-ranging portfolio that encompasses everything related to faculty, oversight of the educational enterprise and prime responsibility for MIT's strategic planning.
In a statement from MIT, Mr Chandrakasan said he is 'deeply honoured" to take on the role of provost.
'Looking ahead, I see myself as a key facilitator, enabling faculty, students, postdocs, and staff to continue making extraordinary contributions to the nation and the world,' he said.
Ms Kornbluth noted that Mr Chandrakasan steps into the provost's role at a 'perilous' time for MIT when some of its most basic operating assumptions – including MIT's ability to count on extensive federal support for its mission of research, education and innovation, and to attract and retain superb talent from around the world – are now uncertain.
'In a time of such intense pressure and potentially historic change, I am particularly grateful that we will be able to draw on Anantha's depth and breadth of experience; his nimbleness, entrepreneurial spirit and boundless energy; his remarkable record in raising funds from outside sources for important ideas; and his profound commitment to MIT's mission,' she said.
The Consulate General of India in New York congratulated Mr Chandrakasan on his appointment as Provost of MIT, noting that he is the first Indian-American to have achieved this feat.
'A distinguished academic and leader, Prof Chandrakasan has remained a strong advocate of India-USA technological & R&D collaboration; has been working with various Indian government and private sector stakeholders towards this objective. We wish him all success in this important responsibility,' the Consulate said.
'In short, the job truly could not be more central to MIT's present and future vitality,' Ms Kornbluth said.
The provost also oversees several affiliated institutes and units and leads a team of vice provosts responsible for the arts; campus space management and planning; faculty; international activities; and Open Learning.
Mr Chandrakasan has served as the dean of the School of Engineering since 2017 and as MIT's inaugural chief innovation and strategy officer since 2024.
Prior to becoming dean, he headed the Department of Electrical Engineering and Computer Science (EECS), MIT's largest academic department, for six years. Kornbluth said she had chosen him as MIT's inaugural chief innovation and strategy officer (CISO) because of his 'can-do attitude, creativity, enthusiasm, strategic insight, fluency across a wide range of subject areas, and gift for engaging industry allies and donors.' Mr Chandrakasan succeeds Cynthia Barnhart, who announced her decision to step down from the role in February.
As MIT's chief academic officer, Mr Chandrakasan will focus on three overarching priorities: understanding institutional needs and strategic financial planning, attracting and retaining top talent, and supporting cross-cutting research, education, and entrepreneurship programming, the MIT statement said.
'Recognising that each school and other academic units operate within a unique context, I plan to engage deeply with their leaders to understand their challenges and aspirations. This will help me refine and set the priorities for the Office of the Provost,' Mr Chandrakasan said.
Mr Chandrakasan also plans to establish a provost faculty advisory group to hear on an ongoing basis from faculty across the five schools and the college, as well as student/postdoc advisory groups and an external provost advisory council, he said adding that his goal is to continue to facilitate excellence at MIT at all levels, it said.
'There is a tremendous opportunity for MIT to be at the centre of the innovations in areas where the United States wants to lead. It's about AI. It's about semiconductors. It's about quantum, biosecurity and biomanufacturing space — but not only that," Mr Chandrakasan said in the MIT statement.
"We need students who can do more than just code or design or build. We really need students who understand the human perspective and human insights. This is why collaborations between STEM fields and the humanities, arts and social sciences, such as through the new MIT Human Insights Collaborative, are so important,' Mr Chandrakasan said.
Mr Chandrakasan earned his BS, MS, and PhD in electrical engineering and computer sciences from the University of California at Berkeley. After joining the MIT faculty, he was director of the Microsystems Technology Laboratories (MTL) from 2006 until he became the head of EECS in 2011.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Eris Lifesciences eyes ‘good' share in semaglutide generics, says COO
Eris Lifesciences eyes ‘good' share in semaglutide generics, says COO

Economic Times

time6 minutes ago

  • Economic Times

Eris Lifesciences eyes ‘good' share in semaglutide generics, says COO

Mr. Krishnakumar Vaidyanathan, Executive Director & Chief Operating Officer Eris Lifesciences looks to leverage its experience in integrated diabetes portfolio to take a lead among the first wave of generic semaglutide anti-diabetic and weight-loss drugs to hit the market early next year, a top official said. The company is looking at a 'good' share of the market, Krishnakumar Vaidyanathan, executive director and chief operating officer of Eris Lifesciences, told ET in an interaction. Semaglutide is the active ingredient in Novo Nordisk's blockbuster drugs Wegovy and Ozempic. Its patent in India will expire in March 2026. 'We are gearing up to be among the first to enter the market post loss of exclusivity,' Vaidyanathan said. 'We expect the overall market for GLP-1 at the end of the first 12 months (after the loss of exclusivity) to be at least 10 million units… And we expect to get a good share of the market.' Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Eris Lifesciences' existing diabetes portfolio includes orals, insulin and GLP-1 in the form of liraglutide. Its network of field representatives, patient connect and service platform in this space gives the firm an advantage over others, Vaidyanathan said. 'We do this day in and day out because of insulin. That gives us the confidence that we'll be able to step this up for GLP-1 as well.'Globally, the GLP-1 market is dominated by Eli Lilly and Novo Nordisk, which are also the two biggest insulin companies in the world. 'Being successful and big in the insulin market provides a huge tailwind when it comes to selling GLPs,' Vaidyanathan said. 'We have combined service with technology and product to create a winning combination in insulin and GLP therapy entry is not any different, which also requires a lot of patient education over and above the service on using the pens,' he said. 'We have an integrated diabetes portfolio because we currently sell GLP-1 in the form of liraglutide.' Dr Reddy's Labs, Sun Pharmaceutical Industries, Cipla, Mankind Pharma, Torrent Pharmaceuticals, and Zydus Lifesciences are also among Indian drugmakers readying to launch generic semaglutide next year. Eris Lifesciences launched liraglutide, a once-a-week GLP-1 product, last September. 'We have taken very good market shares in all the other LOE (loss of exclusivity) opportunities that we have seen in diabetes,' Vaidyanathan said. 'We have taken market ranks of 1 to 5 in each one without exception – vildagliptin, sitagliptin, linagliptin, dapagliflozin and empagliflozin. That gives us the confidence that we should be getting a fair share of the market.' Vishal Manchanda, pharma analyst at brokerage Systematix Group, said its full portfolio of anti-diabetes drugs to offer to diabetologist, spanning all oral and injectable options, should give Eris Lifesciences 'a strong positioning in a market where the large pharma majors like Sun, Lupin, Dr Reddy's, Cipla, Mankind and Zydus come in with their dominant brand presence.'

Vedanta continues winning street confidence: Brokerages forecast strong earnings ahead
Vedanta continues winning street confidence: Brokerages forecast strong earnings ahead

Hans India

time9 minutes ago

  • Hans India

Vedanta continues winning street confidence: Brokerages forecast strong earnings ahead

New Delhi: Major global and Indian brokerages remain optimistic on Vedanta Ltd's performance for FY26, citing stronger LME pricing trends, cost discipline, deleveraging, and a resilient aluminium business among the key growth drivers. These firms have also taken note of the several growth projects scheduled for commissioning or completion in the next few quarters. JP Morgan noted that Vedanta's first quarter consolidated EBITDA was largely in line with estimates, with key segments such as aluminium, oil and gas, and power faring better than its expectations, leading to an overall segmental EBITDA beat. On the earnings trajectory for the current and next fiscal, the firm expects various ongoing initiatives at Vedanta to aid growth. "Vedanta's capacity expansion journey in the aluminium business as well as vertical integration should bring cost advantages. LME prices have also bottomed out and should continue to move higher into FY26-27, likely aiding earnings growth." Echoing similar views on LME prices and its potential benefit, Citi Research cited that Vedanta's parent (Vedanta Resources) leverage is at comfortable levels. It listed potential upside in medium-term aluminium LME prices, lower cost, and the demerger as another positive for Vedanta, while adding that aluminium globally has a limited supply growth. Mumbai-based Nuvama Institutional Equities expects Vedanta to deliver quarter-on-quarter EBITDA growth in Q2. "Q2FY26 EBITDA is likely to increase 10 per cent-plus quarter-on-quarter on the back of higher prices and lower aluminium cost of production. Major aluminium projects are likely to be commissioned in Q2FY26. We reckon net debt/EBITDA ex-Hindustan Zinc shall fall to 1.7x by FY26-end, compared to 2.7x in FY25. Demerger of the business is likely to be concluded in Q4FY26," the firm said in its report. The brokerage expects Vedanta's all major projects except coal blocks to be likely commissioned in the current fiscal, providing volume growth and cost reduction visibility for the company. UK-based Investec stated in its post-earnings report that Vedanta is a key beneficiary of depreciation in the Indian Rupee. Other near-term positives listed by the firm include declining alumina prices and the company offering attractive yields. The firm has retained its buy recommendation on Vedanta. Research firms like Kotak Institutional Equities and IIFL have cited factors like cost efficiencies and deleveraging at both Vedanta Ltd and its parent Vedanta Resources as beneficial factors. Vedanta's adjusted profit after tax jumped 13 per cent year-on-year to Rs 5,000 crore. The company clocked its highest-ever first-quarter EBITDA of Rs 10,746 crore, which was up 5 per cent year-on-year.

SIR in Bihar an 'invasive reconstruction of electoral roll:' Dipankar Bhattacharya
SIR in Bihar an 'invasive reconstruction of electoral roll:' Dipankar Bhattacharya

The Hindu

time9 minutes ago

  • The Hindu

SIR in Bihar an 'invasive reconstruction of electoral roll:' Dipankar Bhattacharya

Describing the Special Intensive Revision (SIR) drive under way in Bihar as 'an invasive reconstruction of the electoral roll,' Dipankar Bhattacharya, general secretary of the Communist Party of India (Marxist-Leninist) Liberation, said States including Kerala should be on guard as it could be applied in other parts of the country as well. 'If they get away with it in Bihar, they will apply it everywhere,' he said, delivering the 24th memorial lecture in memory of the journalist N. Narendran on the topic 'Bihar: Trial run for Mass Disenfranchisement.' 'In fact, some people in Kerala and Tamil Nadu may still be believing that, well, this is something only happening in north India. If it is happening in north India, it is only a matter of time it happens here. No part of India is secure. Every State, every community, every political geography, every social equation, is vulnerable,' he said. The concept of citizenship as Indians have known it no longer remains valid as people will now be forced to prove their citizenship. The migrant workers of Bihar have emerged as one of the most vulnerable sections of electors in the SIR in Bihar, given the Election Commission of India's definition of 'ordinary resident.' This could have implications for Kerala as well, which has a large migrant population, he said. The SIR in Bihar, he said, was not just about rewriting the electoral roll, but it was about rewriting the electoral rules, he said. 'By rewriting the electoral rules, you are rewriting the entire grammar of elections in India,' he said. Mr. Dipankar Bhattacharya said that the INDIA Bloc was the need of the hour, observing that the BJP has grown at the expense of all other parties. 'If we cannot identify who the common enemy is, we will be doing so at our own peril,' he said. He underscored the need for a broad-based, sustained and multi-pronged resistance against what he described as the 'fascist offensive' of the BJP-RSS in the country. On the BJP's 'One Nation, One Election' proposal, Mr. Bhattacharya said it holds grave implications for the concepts of democracy and federalism. 'Every election has its own context. A Lok Sabha election has its own context, an Assembly election has its own context, a panchayat election will have its own context. If you bulldoze, flatten everything into one single narrative, and one single context for the whole elections, there will be nothing left of India's federalism and democracy as we have known it all these years,' he said, adding that the current challenges facing the Indian people is unlike any other in the post-Independence era.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store